ArticleFrontiers in neurology2026

Rehmannioside A alleviates neuroinflammation and cognitive impairments after traumatic brain injury by suppressing microglial activation via the MAPK/NF-κB pathway.

Shiyu Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.